nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Artificial intelligence in anti-obesity drug discovery: unlocking next-generation therapeutics
|
Gangwal, Amit |
|
|
30 |
4 |
p. |
artikel |
2 |
Dissolving microneedles for brain delivery: Recent advances and challenges
|
Kolekar, Kaustubh Ajit |
|
|
30 |
4 |
p. |
artikel |
3 |
Drug development for neglected ultra-rare diseases of no commercial interest: Challenges and opportunities
|
Katakowski, Joseph A. |
|
|
30 |
4 |
p. |
artikel |
4 |
Drug–device combinations in rare diseases: Challenges and opportunities
|
Tataru, E.A. |
|
|
30 |
4 |
p. |
artikel |
5 |
Emerging role of deubiquitinases in modulating cancer chemoresistance
|
Dasharathy, Sukeerthi |
|
|
30 |
4 |
p. |
artikel |
6 |
Enhancing clinical trial outcome prediction with artificial intelligence: a systematic review
|
Qian, Long |
|
|
30 |
4 |
p. |
artikel |
7 |
Gastroretentive drug delivery systems: A holy grail in oral delivery
|
Omidian, Hossein |
|
|
30 |
4 |
p. |
artikel |
8 |
2024 in Review: FDA Approval of New Medicines
|
Kinch, Michael S. |
|
|
30 |
4 |
p. |
artikel |
9 |
IRE1α-mediated UPR activation in gastrointestinal cancers: Adaptive mechanisms and therapeutic potential
|
Soumya, Valappan Veetil |
|
|
30 |
4 |
p. |
artikel |
10 |
Leveraging machine learning for drug repurposing in rheumatoid arthritis
|
Su, Qin-Yi |
|
|
30 |
4 |
p. |
artikel |
11 |
Molecule-rich solutions for achieving novel non-opioid analgesics
|
Liu, Xingxing |
|
|
30 |
4 |
p. |
artikel |
12 |
Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessment
|
Shenton, Jacintha |
|
|
30 |
4 |
p. |
artikel |
13 |
Overview of new indications for novel drugs approved in China between 2018 and 2024
|
Xu, Yang |
|
|
30 |
4 |
p. |
artikel |
14 |
Ramipril, perindopril and trandolapril as potential chemosensitizers in ovarian cancer: Considerations for drug repurposing
|
Regulska, Katarzyna |
|
|
30 |
4 |
p. |
artikel |
15 |
The Six Ds of Exponentials and drug discovery: A path toward reversing Eroom’s law
|
Tropsha, Alexander |
|
|
30 |
4 |
p. |
artikel |
16 |
Tubulin targeting agents and their implications in non-cancer disease management
|
Lal, Samridhi |
|
|
30 |
4 |
p. |
artikel |